STEPHANIE STECKER: Open Payments
NPI 1710576178 · AUSTINTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,217 in 127 payments from 18 companies in 2025. Trend: 2023 $2,331 · 2024 $3,172 · 2025 $2,217
Food & beverage: $2,106Education: $111
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $362 |
| Otsuka America Pharmaceutical, Inc. | 21 | $313 |
| ABBVIE INC. | 18 | $263 |
| Vanda Pharmaceuticals Inc. | 16 | $245 |
| E.R. Squibb & Sons, L.L.C. | 8 | $236 |
| Lundbeck LLC | 16 | $234 |
| Teva Pharmaceuticals USA, Inc. | 9 | $223 |
| Neurocrine BioSciences, Inc. | 5 | $101 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| Alkermes, Inc. | 2 | $36 |
Products named: CAPLYTA, REXULTI, VRAYLAR, FANAPT, COBENFY, ABILIFY MAINTENA, INGREZZA, AUSTEDO XR.
Industry payments across OH — which companies pay providers there.
